在心肌梗塞后的纤维化中信号通路和治疗方法
1Department of Pathology, The 305 Hospital of PLA, Beijing, China.
概括
心肌梗塞 (MI) 导致心脏纤维化. 通过多途径策略针对TGF-β1等关键途径,为心脏病提供了有前途的治疗干预措施.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 再生医学是一种再生医学.
背景情况:
- 心肌梗塞 (MI) 是心肌纤维化的主要原因,显著增加心脏病发病率和死亡率.
- 了解后心脏病发作纤维化背后的分子机制对于开发有效的治疗方法至关重要.
研究的目的:
- 审查心肌梗塞后心肌纤维化所涉及的关键信号通路.
- 总结针对这些途径的最近的治疗策略.
- 突出多途径治疗心脏纤维化治疗方法的潜力.
主要方法:
- 关于包括TGF-β1,PI3K/AKT,STAT3,AMPK,Nrf2,NF-kappaB,NLRP3炎症体,Wnt/b-catenin,MAPK和P53.3在内的信号通路的文献综述.
- 分析各种治疗干预措施,如药物,蛋白质,基因,物理和细胞疗法,以及运动训练.
- 检查TGF-β1通路在纤维细胞调节网络中的中心作用.
主要成果:
- 多种信号通路 (例如,TGF-ß1,PI3K/AKT,STAT3) 涉及到心肌纤维化后心肌梗塞的发展.
- 包括细胞疗法和运动在内的多种治疗方式,通过调节这些途径,显示出缓解纤维化的潜力.
- 该TGF-β1通路作为控制心肌纤维化的复杂网络中的中央调节器出现.
结论:
- 针对特定的信号通路提供了潜在的治疗途径,以减少心肌梗塞之后的心肌纤维化.
- 多途径治疗策略代表了管理心脏纤维化的综合方法.
- 进一步的临床研究对于优化这些策略和改善心脏病患者的治疗结果至关重要.
相关概念视频
01:19Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
01:21Myocarditis I: Introduction
354
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
354
01:14Myocarditis III: Medical Management
168
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
168
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
902
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
902
01:17Intracellular Signaling Affects Focal Adhesions
3.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.5K
01:28Acute Coronary Syndrome IV: Interprofessional Care
205
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
205